Myth 1 # Overcome Premature Ejaculation must be associated to some underlying ailment

Premature ejaculation isn’t an illness, nor is it a ailment nor does it indicate the presence of any underlying condition, nevertheless it definitely exists within the type of clinical diagnosis. Generally it is psychological difficulties which lead to premature ejaculation and not actual ones.

Myth 2 # I can last longer if I stop fantasizing about sexy stuff

Though quite a few people will guidance this technique of distraction and diverting by yourself, in reality it has worked only for some people and for others it doesn’t work. In brief, you are not able to treat this process as being a solution.  Rather it’ll decrease your sensation of feeling the sexual pleasure.  If you would like to command your premature ejaculation, you have to concentrate on your entire body and figure out how to regulate your urge, instead of just diverting by yourself. Having a tiny little bit of train, you’ll manage to do it and take pleasure in total actual satisfaction.

Myth three # some are born with it, some aren’t

It is one more myth I would like to debunk. The ability to manage premature ejaculation isn’t an innate good quality; those that are in a position to do it have earlier masturbatory experiences or might have practiced self command while using help of previous bed partners.  You must fully grasp that ejaculation is simply like urination and you really should train controlling premature ejaculation just the way you regulate your urge to urinate.

Myth 4 # you will be referred to as a quick ejaculator when you cum inside a couple of minutes

This just isn’t wholly true. In many medical definitions there is a specific time limit and when you ejaculate within which you will probably be termed a un controlled ejaculator but to diagnose this problem, there are many other signs or symptoms to be taken into account. A lot of definitions of premature ejaculation usually do not contain time limits.

Myth five # this sexual dysfunction has no remedy

Around the contrary, which includes a little bit of training, majority from the adult men learn how to regulate their premature ejaculation on their very own and there’s just no will need of any type of healthcare intervention or prescriptions. It is possible to read up the world-wide-web or carry advice from other men to study these methods.

Myth 6 # I can treat premature ejaculation with pills

You ought to consider recourse to behavioral methods to command this sexual dysfunction. You can’t cure premature ejaculation with pills as you’ll find no FDA approved tablets as such. But inside the world-wide-web you might find several prescriptions to cure premature ejaculation, but you don’t have to waste income on them.

The Ejaculation Trainer guide basically provides you with a system which other resources fail to realize… A system which ties together the physical, spiritual and mental aspects of overcoming premature ejaculation, and also provides step by step advice, plus it warns you of the common mistakes you should avoid too

Read Full Article

Dapoxetine, a selective serotonin reuptake inhibitor, is the first oral pharmacological agent indicated for the treatment of men aged 18-64 years with premature ejaculation. In four randomized, double-blind, placebo-controlled, multicentre studies of 12-24 weeks’ duration, oral dapoxetine 30 or 60 mg (administered as needed) was effective in the treatment of men with premature ejaculation, inducing significantly (p < 0.001) greater improvements from baseline than placebo in the primary efficacy endpoint (mean intravaginal ejaculatory latency time [IELT] or mean average IELT [defined as the average of IELT values over the previous 4 weeks], as measured by the female partner utilizing a stopwatch). For the most part, dapoxetine recipients achieved significantly better outcomes than placebo recipients with regard to the secondary endpoints, including the Premature Ejaculation Profile (PEP) domains and the Clinical Global Impression or Patient Global Impression ratings of change in premature ejaculation, across these clinical studies. The beneficial effects of dapoxetine therapy on the perceived control over ejaculation and satisfaction with sexual intercourse PEP domains were sustained in a 9-month noncomparative extension phase of two identical 12-week, double-blind studies. Oral dapoxetine therapy for up to 12 months was generally well tolerated in men with premature ejaculation, with the nature of treatment-emergent adverse events generally similar across the clinical studies and between dapoxetine and placebo.

Read Full Article

ABSTRACT Introduction. PSD502 is a novel aerosolized, lidocaine-prilocaine, spray being developed for the treatment of lifelong premature ejaculation. The clinical profile of PSD502 is described in one of two double-blind, placebo-controlled, phase III studies. Aim. To determine the effect of PSD502 on the Index of Premature Ejaculation (IPE) and intravaginal ejaculatory latency (IELT) of men with lifelong PE. Methods. Men with lifelong PE who documented an IELT </= 1 minute with two or more of the first three sexual encounters during a 4-week baseline period were randomized to receive double-blind treatment with PSD502 or placebo for 3 months. Patients completed IPE and Premature Ejaculation Profile questionnaires at entry and monthly visits, and recorded stop-watch timed IELT during each encounter. Safety was assessed by collecting adverse event data and standard safety measures. Main Outcome Measures. Stopwatch timed IELT recordings and a patient-reported outcome questionnaire the IPE were used in this study to determine the effect of PSD502 applied topically 5 minutes before intercourse. Results. Two hundred fifty-six men with PE were randomized from 38 centers in the U.S., Canada, and Poland. The geometric mean IELT over the 3-month treatment period increased from a baseline of 0.56 minute and 0.53 minute in the PSD502 and placebo group respectively to 2.60 and 0.80 minute. There were significantly greater increases in the scores for the IPE domains of ejaculatory control, sexual satisfaction and distress in the PSD502 group than in the placebo group, with a mean 5.0 point difference between treatments in change from baseline in the IPE domain for ejaculatory control, 4.6 point difference in change from baseline in the IPE domain for sexual satisfaction, and a 2.5 point difference in change from baseline in the IPE domain for distress. This was supported by improvements in all secondary endpoints. Conclusion. In this study, PSD502 applied topically to the glans penis 5 minutes before intercourse showed significantly improved ejaculatory latency, ejaculatory control, sexual satisfaction and distress and was shown to be well tolerated by patients and partners. Carson C, and Wyllie M. Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: Results of a phase III, double-blind, placebo-controlled study. J Sex Med **;**:**-**.

Read Full Article

Potential effects of sexual orientation on ejaculatory function have been overlooked in the literature. In anticipation of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V), attempts have been made to formulate universally suitable definitions for different subtypes of premature ejaculation. However, the proposed definitions are centered around intravaginal ejaculation latency time, and little consideration has been given to whether such definitions are applicable to gay or bisexual men. The present study aimed to investigate effects of sexual orientation on premature and delayed ejaculation. When differences in frequencies and patterns of sexual activities were controlled for, there remained no significant effects of sexual orientation on ejaculatory dysfunction.

Read Full Article

Study Type – Aetiology (case control) Level of Evidence 3b OBJECTIVES To investigate the correlation between penile hypersensitivity and premature ejaculation (PE), as defined by the criteria identified by the International Society of Sexual Medicine (ISSM). Penile hypersensitivity as a cause of PE is based on historical clinical neurophysiological data and clinical efficacy of the topical desensitizing agent PSD502 in the treatment of PE. PSD502 is a eutectic-like mixture of two local anaesthetics, lidocaine and prilocaine, whose primary action is to reduce neuronal conduction in sensory afferents. METHODS Historical neurophysiological data was reviewed, together with data from the recent PSD502 clinical trials, including the first published double-blind clinical trial data evaluating a topical desensitizing agent in a population of men with PE, as per the new ISSM definition. The clinical profile of PSD502, based on its local anaesthetic properties, is used as a surrogate index of the role of sensory afferents in the ejaculatory reflex. RESULTS The published data does not support unequivocally penile hypersensitivity as the cause of PE. Interpretation of the data is hampered by the variability of the populations described as having PE across studies. Data from the PSD502 clinical trials clearly shows that PSD502 increases ejaculatory latency, and improves control and sexual satisfaction when applied topically to men with PE 5 min before intercourse, enabling subjects to delay ejaculation up to six times longer than those who used a placebo. CONCLUSION The clinical profile of PSD502 lends credibility to the penile hypersensitivity hypothesis for PE. The predominant action of local anaesthetics is to reduce neuronal firing in sensory afferents; the clinical profile of PSD502, which shows improvement of ejaculatory function in the absence of a generalized reduction in penile sensitivity, can most readily be explained based on an underlying hypersensitivity in patients with PE.

Read Full Article

Study Type – Aetiology (case control) Level of Evidence 3b OBJECTIVES To investigate the correlation between penile hypersensitivity and premature ejaculation (PE), as defined by the criteria identified by the International Society of Sexual Medicine (ISSM). Penile hypersensitivity as a cause of PE is based on historical clinical neurophysiological data and clinical efficacy of the topical desensitizing agent PSD502 in the treatment of PE. PSD502 is a eutectic-like mixture of two local anaesthetics, lidocaine and prilocaine, whose primary action is to reduce neuronal conduction in sensory afferents. METHODS Historical neurophysiological data was reviewed, together with data from the recent PSD502 clinical trials, including the first published double-blind clinical trial data evaluating a topical desensitizing agent in a population of men with PE, as per the new ISSM definition. The clinical profile of PSD502, based on its local anaesthetic properties, is used as a surrogate index of the role of sensory afferents in the ejaculatory reflex. RESULTS The published data does not support unequivocally penile hypersensitivity as the cause of PE. Interpretation of the data is hampered by the variability of the populations described as having PE across studies. Data from the PSD502 clinical trials clearly shows that PSD502 increases ejaculatory latency, and improves control and sexual satisfaction when applied topically to men with PE 5 min before intercourse, enabling subjects to delay ejaculation up to six times longer than those who used a placebo. CONCLUSION The clinical profile of PSD502 lends credibility to the penile hypersensitivity hypothesis for PE. The predominant action of local anaesthetics is to reduce neuronal firing in sensory afferents; the clinical profile of PSD502, which shows improvement of ejaculatory function in the absence of a generalized reduction in penile sensitivity, can most readily be explained based on an underlying hypersensitivity in patients with PE.

Read Full Article

Importance of the field: Premature ejaculation (PE) is a common male sexual disorder which is associated with substantial personal and interpersonal negative psychological factors. Drug treatment of PE with an off-label antidepressant selective serotonin reuptake inhibitor (SSRI) drug is common. The lack of an approved drug and total reliance on off-label treatment represents a substantial unmet treatment need. Areas covered in this review: Medline and the proceedings of major international and regional scientific meetings during the period 1994 – 2010 were searched for publications or abstracts using the word ‘dapoxetine’ in the title, abstract or keywords. This search was then manually cross-referenced for all papers. This review encompasses studies of dapoxetine pharmacokinetics, animal studies, human phase I, II and III efficacy and safety studies and drug-interaction studies. Dapoxetine is a potent SSRI, which is administered on demand 1 – 3 h before planned sexual contact. Dapoxetine is rapidly absorbed and eliminated, resulting in minimal accumulation and has dose-proportional pharmacokinetics, which are unaffected by multiple dosing. Dapoxetine 30 and 60 mg has been evaluated in five randomized, double-blind, placebo-controlled studies in 6,081 men aged >/= 18 years. Outcome measures included stopwatch-measured intravaginal ejaculatory latency time (IELT), Premature Ejaculation Profile (PEP) items, clinical global impression of change (CGIC) in PE, and adverse events. Mean IELT, all PEP items and CGIC improved significantly with both doses of dapoxetine versus placebo (p < 0.001 for all). The most common adverse events included nausea, dizziness and headache, and evaluation of validated rated scales demonstrated no SSRI class-related effects with dapoxetine use. What the reader will gain: Readers will gain insight into the epidemiology, pathophysiology and contemporary drug treatment of premature ejaculation. Take home message: Dapoxetine, as the first drug developed for PE, is an effective and safe treatment for PE and represents a major advance in sexual medicine.

Read Full Article

Know What Kind of Male Enhancement Product You’re Taking

Also of great importance, you don’t really know what’s in the product you’re taking, even with some of the most popular enhancement products available. If you’re going to take enhancement products, you want to know what they are made of and that they are safe.

One easy way to make a fast judgement about safety is to only buy products made in the USA or EU (European Union). They have the strictest of manufacturing and health standards, and use only recognizably safe ingredients.

The other choice to take is all natural vs synthetic ingredients. Many male enhancement products use natural ingredients that have been used for decades (if not longer!), and have a long track record of safe usage. Sythetic ingredients have to be tested to be proven to be safe, but many do not have such a proven track record of safety.

How Do Male Enhancement Pills Work?

Male enhancement pills work by increasing the hormone levels in the body while stimulating circulation and blood flow in the genital area. By improving circulation and increasing the blood flow to the penis, they actually increase the strength and duration of your erections. They actually give you a healthier penis, which will help to prevent premature ejaculation. A healthy and hard penis always looks larger, too!

Male enhancement pills can add a real boost to your bedroom and sex life. Those days of stress, long working hours, bad diet, and not enough sleep, all play their toll. More and more men are turning to natural male enhancement products not because they have any specific medical issue, but to simply deal with the rush of life.

Male enhancement and aphrodisiac products can offer you harder and longer erections, increased semen production, fewer premature ejaculations and an increase in stamina and sex drive. If you’re going to be using male enhancement pills, be sure choose the ones that offer a guarantee of safety, and with some kind of proven track record – after all, it is your health.

For More Male Enhancement Products and Techniques Advice visit our site: About Male Enhancement

We’re unclear as to precisely why a woman would wish to “increase testosterone,” or “boost virility.” Although this product claims to become suitable for each males and women, we cannot assist but really feel that its mechanism caters more to male requirements. In addition, we feel that this product’s ingredient list is somewhat incomplete, in spite of the inclusion of the few quality elements. We will review this product for its ability to equally enhance the sexual experience for each genders.

Ingredients at a glance

This formula might contain some with the following elements: Tribulus Terrestris, Avena Sativa and Horny Goat Weed.

Ingredients in Focus

Tribulus Terrestris is known to become a single of the much more efficient sexual enhancement ingredients presently accessible. This herbal component is recognized to normally improve testosterone and improve potency. Whilst both of these outcomes would definitely be of benefit to most men, we wonder how they might be useful to ladies. The ingredient, Avena Sativa, which is the scientific name for oats, isn’t proven as a sexual enhancer at this time, in spite of its historic use for this objective. One expert states, “Avena sativa has been utilized medicinally because the Middle Ages, yet I have not arrive across any reference to any aphrodisiac advantage that has ever been noted or documented in several hundred many years of use.”

We also would have preferred to determine some other, more targeted ingredients which are known to enhance male sexuality, such as Yohimbe, Panax Ginseng and Damiana. We speculate if possibly these ingredients are already excluded because of their male-specific sexual mechanisms. If this may be the situation, we really feel that this product eventually dilutes and compromises its potential by attempting to cater to each genders.

Learn more about Herbal Ignite Review now